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ANNEXURE
                                         INTRODUCTION
Acute respiratory infections constitute one of the principal causes of morbidity 
and  mortality  in  children  less  than  five  years  of  age  in  developing  countries.  It  is 
estimated that  3.9 million children die annually  from ARI,  most  of  them been from 
developing countries1,2.  Pneumonia, refers to an infection of the lungs, which can be 
caused by a variety of microorganisms, including viruses, bacteria, fungi, and parasites.
Signs and symptoms
Symptoms of pneumonia vary, depending on the age of the child and the cause of 
pneumonia.  Some common symptoms include:
 Fever
 Chills 
 Cough 
 Unusually rapid breathing
 Breathing with grunting or wheezing sounds 
 Labored breathing that makes a child's rib muscles retract  
 Vomiting 
 Chest pain 
 Abdominal pain
 Decreased activity 
 Loss of appetite (in older children) or poor feeding (in infants) 
 In extreme cases, cyanosis.
When pneumonia is caused by bacteria, the child usually becomes sick relatively 
quickly and experiences the sudden onset of high fever and unusually rapid breathing. 
When pneumonia is caused by viruses, symptoms tend to appear more gradually and are 
often less severe than in bacterial pneumonia. Wheezing may be more common in viral 
pneumonia.  In  developing  countries,  like  India,  with  high  infant  mortality  rates, 
pneumonia is contributed mainly by bacteria. Agents causing pneumonia are far wide 
when compared to adult population.
Pathophysiology of pneumonia:3
Viral pneumonia
Viruses reach the lungs when airborne droplets are inhaled through the mouth and 
nose. Once in the lungs, the virus invades the cells lining the airways and alveoli. This 
invasion often leads to cell death, either when the virus directly kills the cells, or through 
a type of cell self-destruction called apoptosis. When the immune system responds to the 
viral infection, even more lung damage occurs. White blood cells, mainly lymphocytes, 
activate  certain  chemical  cytokines which  allow fluid  to  leak  into  the  alveoli.  This 
combination  of  cell  destruction  and  fluid-filled  alveoli  interrupts  the  normal 
transportation of oxygen into the bloodstream. In addition to damaging the lungs, many 
viruses affect other organs and thus disrupt many body functions. Viruses can also make 
the body more susceptible to bacterial infections; bacterial pneumonia often complicates 
viral pneumonia.  Viral pneumonia is commonly caused by viruses such as  influenza 
virus,  respiratory  syncytial  virus (RSV),  adenovirus,  and  metapneumovirus.  Herpes 
simplex  virus is  a  rare  cause  of  pneumonia  except  in  newborns.  Those  with  a 
compromised immune system are also at risk of pneumonia caused by cytomegalovirus 
(CMV).
Bacterial pneumonia
Bacteria typically enter the lung when airborne droplets are inhaled, but can also 
reach the lung through the bloodstream, when there is an infection in another part 
of the body. Many bacteria live in parts of the upper respiratory tract, such as 
the nose,  mouth and sinuses,  and can easily  be inhaled into the alveoli.  Once 
inside, bacteria may invade the spaces between cells and between alveoli through 
connecting  pores.  This  invasion  triggers  the  immune  system to  recruit 
neutrophils. The neutrophils  engulf and kill the offending organisms, and also 
release  cytokines, causing a generalised activation of the immune system. This 
leads to the fever, chills and fatigue, common in bacterial and fungal pneumonia. 
The neutrophils, bacteria, and fluid from surrounding blood vessels fill the alveoli 
and interrupt normal oxygen transportation.
Bacteria often travel from an infected lung into the bloodstream, causing serious 
or  even  fatal  illness  such  as  septic  shock with  low blood  pressure  and  damage  to 
multiple organs including the  brain,  kidneys, and heart. Bacteria can also travel to the 
area between the lungs and the chest wall (the  pleural cavity) causing a complication 
called empyema.
The most common causes of bacterial pneumonia are Streptococcus pneumoniae, 
other  Gram-positive  bacteria and  ‘atypical’  bacteria.  The  types  of  Gram-positive 
bacteria  that  cause  pneumonia  can be  found in  the nose  or  mouth  of  many healthy 
people.  Streptococcus pneumoniae, often called "pneumococcus", is the most common 
bacterial  cause  of  pneumonia  in  all  age  groups  except  newborn  infants.  Another 
important Gram-positive cause of pneumonia is Staphylococcus aureus. Gram-negative 
bacteria  cause  pneumonia  less  frequently  than  gram-positive  bacteria.  Some  of  the 
Gram-negative  bacteria  that  cause  pneumonia  include  Haemophilus  influenzae, 
Klebsiella  pneumoniae,  Escherichia  coli,  Pseudomonas  aeruginosa and  Moraxella 
catarrhalis.  These bacteria often live in the  stomach or intestines and may enter the 
lungs  if  vomitus  is  inhaled.  ‘Atypical’  bacteria  which  cause  pneumonia  include 
Chlamydophila pneumoniae, Mycoplasma pneumoniae, and Legionella pneumophila.
Common causes of pneumonia 
Newborns : Group B Streptococcus (GBS), respiratory 
syncytial virus (RSV).
Infants  
Viruses :  Parainfluenza viruses, influenza virus, 
adenovirus,  and  respiratory  syncytial  virus  (RSV), 
cytomegalovirus.
Atypical organisms : Chlamydia trachomatis, Ureaplasma 
urealyticum, and Pneumocystis carinii (PCP). 
Bacteria :  B. pertussis, Streptococcus pneumoniae, 
Haemophilus influenzae, Mycobacterium
tuberculosis. 
Young children 
Viruses : Parainfluenza viruses, influenza virus, 
adenovirus and respiratory syncytial virus 
Atypical organisms: Mycoplasma pneumoniae.
Bacterial: Pneumococcus, Mycobaterium tuberculosis.
Older children and adolescents: 
Atypical organisms: Mycoplasma pneumoniae, Chlamydia 
trachomatis.
Bacterial: Pneumococcus, B. pertussis, Mycobaterium 
tuberculosis.
Types of pneumonia
Community-acquired  pneumonia: Community-acquired  pneumonia (CAP)  is 
infectious pneumonia in a person who has not recently been hospitalized. CAP is the 
most common type of pneumonia. The most common causes of CAP differ depending 
on a  person's  age,  but  they  include  Streptococcus  pneumoniae,  viruses,  the  atypical 
bacteria, and  Haemophilus influenzae. Overall,  Streptococcus pneumoniae is the most 
common cause of community-acquired pneumonia worldwide.
Hospital-acquired  pneumonia: Hospital-acquired  pneumonia,  also  called 
nosocomial pneumonia,  is  pneumonia  acquired  during  or  after  hospitalization  for 
another  illness  or  procedure with  onset  at  least  72 hrs  after  admission.  The  causes, 
microbiology, treatment and prognosis are different from those of community-acquired 
pneumonia. Up to 5% of patients admitted to a hospital for other causes subsequently 
develop pneumonia. Hospitalized patients may have many risk factors for pneumonia, 
including  mechanical  ventilation,  prolonged  malnutrition,  underlying  heart and  lung 
diseases, decreased amounts of stomach acid, and immune disturbances. Additionally, 
the microorganisms a person is exposed to in a hospital are often different from those at 
home . Hospital-acquired microorganisms may include resistant bacteria such as MRSA, 
Pseudomonas, Enterobacter, and Serratia. Ventilator-associated pneumonia (VAP) is a 
subset of hospital-acquired pneumonia. VAP is pneumonia which occurs after at least 48 
hours of intubation and mechanical ventilation.
Other types of pneumonia
• Severe acute respiratory syndrome (SARS)
SARS is a highly contagious and deadly type of pneumonia which first occurred 
in 2002 after initial outbreaks in  China. SARS is caused by the  SARS coronavirus, a 
previously unknown pathogen. New cases of SARS have not been seen since June 2003.
• Bronchiolitis obliterans organizing pneumonia (BOOP)
BOOP is caused by inflammation of the small  airways of the lungs. It  is also 
known as cryptogenic organizing pneumonitis (COP).
• Eosinophilic pneumonia
Eosinophilic  pneumonia  is  invasion  of  the  lung  by  eosinophils.  Eosinophilic 
pneumonia often occurs in response to infection with a  parasite or after exposure to 
certain types of environmental factors.
• Chemical pneumonia
Chemical pneumonia (usually called chemical pneumonitis) is caused by chemical 
toxins such as  pesticides, which may enter the body by  inhalation or by skin contact. 
When the toxic substance is an oil, the pneumonia may be called lipoid pneumonia.
• Aspiration pneumonia
Aspiration pneumonia (or aspiration pneumonitis) is caused by aspirating foreign 
objects which are usually oral or gastric contents, either while eating, or after reflux or 
vomiting which results in bronchopneumonia. The resulting lung inflammation is not an 
infection but can contribute to one, since the material aspirated may contain anaerobic 
bacteria or other unusual causes of pneumonia. Aspiration is a leading cause of death 
among hospital and  nursing home patients, since they often cannot adequately protect 
their airways and may have otherwise impaired defenses.
Diagnosis of pneumonia
Complete  blood  count:  WBC  count  is  often  increased  with  a  polymorphic 
predominance in bacterial infections4,5. Lymphocytic predominance may be seen in viral 
pneumonias, pertussis and atypical infections.
Cultures: In the cooperative older child with a productive cough, a sputum Gram 
stain is useful. Sputum cultures and immunofluorescent antibody testing may be useful. 
Bactec cultures (sputum or blood) are useful to isolate the organisms. 
Imaging Studies:  Chest  x-ray PA view is  the diagnostic test  for  pneumonias. 
Sometimes  to  differentiate  from  a  syn-pneumonic  effusion,  a  USG  chest  may  be 
required. In rare cases of children who have an effusion or an empyema identified on 
CXR, a CT scan may be needed to further define the scope of the problem.
Mantoux test: To diagnose pneumonia due to mycobaterial tuberculosis.
Cold agglutinin test: A bedside cold agglutinin test may help confirm the clinical 
suspicion of mycoplasmal infection. This test is performed by placing a small amount of 
blood in a specimen tube containing anticoagulant and inserting this into a cup filled 
with ice water. After a few minutes in the cold water, the tube is held up to the light, 
tilted slightly, and slowly rotated. Small clumps of red blood cells coating the tube are 
indicative of a positive test result. This test is positive only in about one half of the cases 
of mycoplasmal infection and has high chances of false positive reactions. 
Other tests:  If  there  is  presence  of  pleural  fluid,  pleural  fluid  aspiration  and 
culture and microscopy. 
Etiological  diagnosis of pneumonia is  very difficult  in young children because 
sputum  is  not  readily  available.  Rapid  diagnostic  procedures  like  counter  immune 
electrophoresis, Elisa, latex agglutination have a very low sensitivity. Only culture of 
lung  aspirates  and  blood  cultures  will  provide  an  etiological  diagnosis.  Ideal 
management in treating pneumonia is by rapidly establishing etiological diagnosis and 
prescribing antimicrobials. However clinical, laboratory and radiological features do not 
reliably distinguish between bacterial and viral cause. Segmental and lobar consolidation 
is  even  caused  by  viruses  though  pathognomonic  for  bacterial  etiology.  Diffuse 
infiltrates are also caused by bacteria though more commonly caused by viruses. Total 
count, differential count, CRP, ESR do not reliably distinguish between bacterial and 
viral etiology.  The Gold standard for establishing etiological diagnosis is only by way 
of culture of lung aspirates which is practically impossible in developing countries. So, 
even in developed countries, etiological diagnosis of pneumonia is established only in 
less than one-fourth. This calls for empirical treatment of pneumonia with antimicrobials
Treatment of pneumonia: 
Oxygen is required if there is grunting, flaring, severe tachypnoea, and retractions.
Bacterial Pneumonia: Antibiotics: oral or intravenous  
Penicillins:  They  are  appropriate  first-line  agents  in  children  in  whom 
pneumococcal disease is strongly suspected6,7. They have limited activity against gram-
negative bacteria due to resistance.
• Amoxicillin: 40 mg/kg/day PO divided tid/ 100 mg/kg/day IV tid
• Penicillin V: 40 mg/kg/d PO divided qid
• Crystalline Penicillin: 1,00,000  units/kg/day IV in 6 divided doses.
• Ampicillin/sulbactum: 40mg/kg/day PO divided tid, 100 mg/kg/day IV qid
• Amoxicillin/clavulanic acid: 40mg/kg/d PO divided tid, 100 mg/kg/d IV tid  
Cephalosporins: First generation cephalosporins: They are useful against Gram positive 
organisms and Proteus mirabilis, H influenzae, Escherichia coli, Klebsiella pneumoniae, 
and Moraxella catarrhalis.
• Cephalexin: 50 mg/kg/day PO bid
• Cefadur : 30-50 mg/kg/day PO bid.
• Cefuroxime:30 mg/kg/d PO bid, IV:150-200 mg/kg/d IV tid.
• Cefalothin: 50 mg/kg/day PO qid / 100 mg/kg/day IV qid.
Second  generation  cephalosporin:  They  are  useful  against  Gram  positive 
organisms and have limited activity against Gram negative organisms. 
• Cefaclor: 20-40 mg/kg/day PO tid. 
Third  generation  cephalosporins:  They  are  broad-spectrum  antibiotics  having 
good Gram-negative activity.
• Cefixime: 8 mg/kg/day PO bid.
• Ceftriaxone: 50-100 mg/kg/d IV/IM bd not to exceed 1 g.
• Cefotaxime: 100-200 mg/kg/d IV/IM divided q6-8h.
• Cefpodoxime: 10 mg/kg/d PO divided bid
• Cefprozil: 30 mg/kg/d PO divided bid
Chloramphenicol:  It  is  a  bacteriostastic  drug  having  good  Gram positive  and 
Gram negative coverage.  It  is  given along with penicillin and is especially useful in 
patients with H. influenza infections. Dose: 100mg/kg/day IV/IM. 
Cotrimoxazole : 21 mg/kg/day PO/IV for 21 days. Useful for PCP pneumonia. 
Macrolides:  They  are  used  for  treatment  of  staphylococcal  and  streptococcal 
infections.  Also  used  in  the  treatment  of  atypical  pneumonias  due  to  mycoplasma, 
chlamydia.
• Erythromycin: 30-50 mg/kg/d PO divided q6-8h. 
• Clarithromycin: 15 mg/kg/d PO divided q12h.
• Azithromycin: Day 1: 10 mg/kg PO once; not to exceed 500 mg/d Days 2-5: 5 
mg/kg PO qd; not to exceed 250 mg/d.
Vancomycin is  used  in  children  with  penicillin  resistant  streptococci  and 
methicillin resistant staphylococci. Dose: 45-50 mg/kg/day IV qds
Viral pneumonia 
• RSV:  Serious  infections  with  this  organism  usually  occur  in  infants  with 
underlying  lung  disease.  Aerosolized  ribavirin  can  be  given  to  severely 
affected infants. 
• Herpes virus: Acyclovir is available for treatment of these pneumonias. Dose: 
10 mg/kg/dose IV q8h; infuse over 1 h 
• Influenza A pneumonia, which is particularly severe or when it occurs in a 
high-risk patient, may be treated with amantadine. 
• Children  who  are  toxic:  Antibiotic  therapy  should  include  vancomycin 
(particularly  in  areas  where  penicillin  resistant  streptococci  have  been 
identified) and a cephalosporin. 
Integrated Management of Neonatal and Childhood Illnesses
WHO/UNICEF have  developed  a  new approach  for  tackling  the  major 
diseases  of  early  childhood called  the  Integrated  Management  of  Childhood 
Illnesses8(IMCI).  Studies show that children presenting with any illness often 
suffer  from  more  than  one  disease.  For  instance,  a  child  presenting  with 
diarrhoea  may  also  be  malnourished  and  may  not  have  received  the 
immunization  as  per  the  National  Immunization  schedule.  The  integrated 
approach ensures that all relevant needs of the child are looked at and attended 
to, during the contact of the child with the health workers.
The IMNCI package has been developed by experts including the Child 
Health Researchers, academicians, the Indian Academy of Pediatrics (IAP) and 
the National Neonatology Forum (NNF) to adapt it for the specific requirements 
of children in India. Since newborn care is an important issue for bringing down 
the infant mortality rate in India, this aspect has been included in the package 
adapted by India. This package includes the following interventions 8 :
Care of Newborns and Young Infants (infants under 2 months)
• Keeping the child warm.
• Initiation  of  breastfeeding  immediately  after  birth  and  counseling  for 
exclusive  breastfeeding and non-use of pre lacteal feeds.  
• Cord, skin and eye care.
• Recognition of illness in newborn and management and/or referral.
• Immunization
• Home visits in the postnatal period.
Home visits are an integral part of this intervention. Home visits by health 
workers (ANMs, AWWs, ASHAs and link volunteers) help mothers and families 
to  understand and provide  essential  newborn  care  at  home and detect  and 
manage newborns with special needs due to low birth weight or sickness.
Three home visits are to be provided to every newborn starting with first 
visit on the day of birth (day 1) followed by visits on day 3 and day 7.  For low 
birth weight babies, 3 more visits (total of six visits) are to be undertaken before 
the baby is one month of age. The details of these visits are given in the training 
package. 
In  addition,  the opportunity of  home visit  is  to be used for  the care of 
mothers during the post-partum period. This will help mothers and families on 
how to recognize and manage minor conditions and will ensure timely referral of 
severe cases.
Care of Infants (2 months to 5 years)
• Management  of  diarrhoea,  acute  respiratory  infections  (pneumonia) 
malaria, measles, acute ear infection, malnutrition and anemia.
• Recognition of illness and at risk conditions and management/referral)
• Prevention and management of Iron and Vitamin A deficiency.
• Counseling on feeding for all children below 2 years 
• Counseling on feeding for malnourished children between 2 to 5 years.
• Immunization
After neonatal period, IMNCI package is accessed by the family for their 
newborns/children  from  the  health  workers  in  the  community  (ANM,  AWW, 
ASHA or link volunteer) or providers at the facility (PHC/CHC/FRU).
The current WHO strategy for control of mortality due to ARI relies heavily 
on  STANDARDISED  CASE  MANAGEMENT9,10.  This  includes  utilization  of 
simple signs and symptoms with high sensitivity and specificity to be adopted at 
first  level  health facilities by paramedics.  Thus among children with ARI four 
main groups have been identified.
• Very severe disease
• Severe pneumonia.
• Pneumonia 
• No pneumonia
CLASSIFICATION OF ILLNESS
Very severe disease:
Signs:          
 Abnormally sleepy or difficult to wake
 Stridor
 Severe malnutrition
 Not able to drink
 Convulsions
Treatment:
 Refer URGENTLY to hospital
 Give first dose of antibiotic
 Treat fever
 Treat wheeze if audible 
Severe pneumonia:
Signs:                 
 Chest indrawing:                                  
 Grunt
 Cyanosis
      Treatment:
 Refer URGENTLY to hospital
 Give first dose of antibiotic
Pneumonia:
      Signs:
 No chest indrawing
 Fast breathing 
2-12 months: Respiratory rate ≥  50/min  
                           12-59 months: Respiratory rate ≥ 40/min 
       Treatment: 
 Give antibiotic
 Home care
 Review after two days or if getting worse
No pneumonia:
        Signs:    
 No chest indrawing 
 No fast breathing
       Treatment:
 Home care
 Treat fever  and wheeze if present    
The  major  clinical  guidelines  for  the  diagnosis  of  pneumonia  pertain  to  fast 
breathing and other features of respiratory distress like chest indrawing, central cyanosis 
or  inability  to  drink.  An  identical  clinical  presentation  may  occur  in  several  other 
potentially  fatal  conditions  that  necessitate  different  therapeutic  modalities.  These 
include acute exacerbation of asthma, congestive cardiac failure, metabolic acidosis and 
raised intracranial pressure.
At  the  time  of  conception  of  these  simple  guidelines   in  the  early  1980s, 
pneumonia could have been the predominant condition with this clinical presentation. 
However,  it  is  possible  that  with  the  passage  of  time,  the  epidemiology  of  various 
conditions presenting with fast breathing and other features of respiratory distress may 
have considerably altered. 
Amongst  the  above  mentioned  other  causes  of  rapid  breathing,  there  is  now 
enough data globally to prove that the prevalence and severity of asthma is increasing in 
all  age groups  11,12,13,14.  In this context,  it  is  also important  to appreciate that asthma 
related fatalities do occur and can be largely prevented by an accurate diagnosis and 
early institution of appropriate therapy including broncho-dilators 15,16.
For  logistic  reasons,  the  WHO  recommended  case  management  is  structured 
towards  treatment  as  pneumonia  in  preference  to  acute  asthma.  It  is  warned  that 
wheezing can occur during pneumonia and therefore, care must be taken when treating 
wheezing not to miss treating pneumonia with an antibiotic  17,18. Further, the need for 
bronchodilator therapy is guided by the presence of a wheeze which for paramedical 
personnel pertains to only an estimated one-third  episodes in which the wheeze may be 
audible without the aid of a stethoscope. Thus, according to the current guidelines, in a 
child  with  cough  and  rapid  breathing,  there  is  a  predilection  for  over-treatment  for 
pneumonia with antibiotics  and for  under-treatment for  asthma with bronchodilators. 
There is thus an urgent need for refining the available algorithm for case management to 
reliably differentiate pneumonia from acute asthma19.
ASTHMA 
Asthma is a chronic inflammatory disorder of the airways characterized by an 
obstruction of airflow, which may be completely or partially reversed with or without 
specific  therapy20.  Airway inflammation is  the result  of  interactions between various 
cells, cellular elements, and cytokines. In susceptible individuals, airway inflammation 
may  cause  recurrent  or  persistent  bronchospasm,  which  causes  symptoms  including 
wheezing,  breathlessness,  chest  tightness,  and  cough,  particularly  at  night  or  after 
exercise. Approximately 500,000 annual hospitalizations (34.6% in persons <18 y) are 
because of asthma. The cost of illness related to asthma is around $6.2 billion. Each 
year,  an  estimated  1.81  million  people  (47.8%)  require  treatment  in  the  emergency 
department. Among children and adolescents aged 5-17 years,  asthma accounts for a 
loss of  10 million school days and costs caretakers $726.1 million because of  work 
absence. Globally,  morbidity and mortality associated with asthma have increased over 
the  last  2  decades.  This  increase  is  attributed  to  increasing  urbanization.  Despite 
advancements in our understanding of asthma and the development of new therapeutic 
strategies, the morbidity and mortality rates due to asthma definitely increased between 
1980 and 1995. In most children, asthma develops before they are aged 5 years, and, in 
more than half, asthma develops before they are aged 3 years. Among infants, 20% have 
wheezing with only upper respiratory tract infections (URTIs), and 60% no longer have 
wheezing when they are aged 6 years.  Many of these children were called ‘transient 
wheezers’.  They  tend  to  have  no  allergies,  although  their  lung  function  is  often 
abnormal. These findings have led to the idea that they have small lungs. Children in 
whom wheezing begins early,  in conjunction with allergies,  are more likely to have 
wheezing when they are aged 6 and 11 years. Similarly, children in whom wheezing 
begins after they are aged 6 years often have allergies, and the wheezing is more likely 
to continue when they are aged 11 years. 
Symptoms and signs:
 Cough 
 Fast breathing
 Retractions
 Decreased activity
 Grunt and wheeze (audible and auscultatory)
 Cyanosis, in extreme cases.
Pathophysiology:  Interactions between environmental and genetic factors result 
in  airway  inflammation,  which  limits  airflow and  leads  to  functional  and  structural 
changes in the airways in the form of bronchospasm, mucosal edema, and mucus plugs. 
Airway  obstruction  causes  increased  resistance  to  airflow  and  decreased 
expiratory flow rates. These changes lead to a decreased ability to expel air and may 
result  in  hyperinflation.  The  resulting  overdistention  helps  maintain  airway  patency, 
thereby improving expiratory flow; however, it  also alters pulmonary mechanics and 
increases the work of breathing. 
Hyperinflation compensates for the airflow obstruction, but this compensation is 
limited when the tidal volume approaches the volume of the pulmonary dead space; the 
result is alveolar hypoventilation. Uneven changes in airflow resistance, the resulting 
uneven distribution of  air,  and alterations  in  circulation from increased intraalveolar 
pressure  due  to  hyperinflation  all  lead  to  ventilation-perfusion  mismatch.  Hypoxic 
vasoconstriction also contributes to this mismatch. 
In  the  early  stages,  when  ventilation-perfusion  mismatch  results  in  hypoxia, 
hypercarbia  is  prevented  by  the  ready  diffusion  of  carbon  dioxide  across  alveolar 
capillary membranes. Thus, asthmatic patients who are in the early stages of an acute 
episode have hypoxemia in the absence of carbon dioxide retention. Hyperventilation 
triggered by the hypoxic drive also causes a decrease in PaCO2. An increase in alveolar 
ventilation  in  the  early  stages  of  an  acute  exacerbation  prevents  hypercarbia.  With 
worsening obstruction and increasing ventilation-perfusion mismatch,  carbon dioxide 
retention occurs.  In the early stages of an acute episode, respiratory alkalosis results 
from  hyperventilation.  Later,  the  increased  work  of  breathing,  increased  oxygen 
consumption,  and  increased  cardiac  output  result  in  metabolic  acidosis.  Respiratory 
failure leads to respiratory acidosis. 
Chronic inflammation of the airways is associated with increased bronchial hyper-
responsiveness,  which  leads  to  bronchospasm  and  typical  symptoms  of  wheezing, 
shortness of breath, and coughing after exposure to allergens, environmental irritants, 
viruses, cold air, or exercise. In some patients with chronic asthma, airflow limitation 
may  be  only  partially  reversible  because  of  airway  remodeling  (hypertrophy  and 
hyperplasia of smooth muscle, subepithelial fibrosis) that occurs with chronic untreated 
disease. 
New insights  in  the  pathogenesis  of  asthma  suggest  the  role  of  lymphocytes. 
Airway inflammation in asthma may represent a loss of normal balance between two 
"opposing" populations of Th lymphocytes. Two types of Th lymphocytes have been 
characterized: Th1 and Th2. Th1 cells produce IL-2 and IFN-γ, which are critical in 
cellular  defense  mechanisms  in  response  to  infection.  Th2,  in  contrast,  generates  a 
family of cytokines (IL-4, -5, -6, -9, and -13) that can mediate allergic inflammation. 
The current "hygiene hypothesis"21 of asthma illustrates how this cytokine imbalance 
may  explain  some  of  the  dramatic  increases  in  asthma  prevalence  in  Westernized 
countries. This hypothesis is based on the assumption that the immune system of the 
newborn  is  skewed toward  Th2 cytokine  generation.  Following birth,  environmental 
stimuli such as infections will activate Th1 responses and bring the Th1/Th2 relationship 
to an appropriate balance. 
Evidence  exists  that  the  prevalence  of  asthma  is  reduced  in  association  with 
certain infections (Mycobacterium tuberculosis,  measles,  or hepatitis  A); exposure to 
other children (eg, presence of older siblings and early enrollment in childcare); and less 
frequent  use  of  antibiotics.  Furthermore,  the  absence  of  these  lifestyle  events  is 
associated with the persistence of a Th2 cytokine pattern. 
Under  these  conditions,  the  genetic  background  of  the  child,  with  a  cytokine 
imbalance toward Th2, will set the stage to promote the production of IgE antibody to 
key  environmental  antigens  (e.g.,  dust  mites,  cockroaches,  Alternaria, and  possibly 
cats). Therefore, a gene-by-environment interaction occurs in which the susceptible host 
is exposed to environmental factors that are capable of generating IgE, and sensitization 
occurs. A reciprocal interaction seems to exist between the two subpopulations in which 
Th1 cytokines can inhibit Th2 generation and vice versa. Allergic inflammation may be 
the result of an excessive expression of Th2 cytokines. Alternately, the possibility that 
the loss of normal immune balance arises from a cytokine dysregulation in which Th1 
activity in asthma is diminished has been suggested in recent studies. 
CLASSIFICATION OF CHRONIC ASTHMA:
The severity of asthma is classified as: 
• mild intermittent
• mild persistent
• moderate persistent
• severe persistent
according to the frequency and severity of symptoms, including nocturnal symptoms, 
characteristics of acute episodes, and pulmonary function.
Mild intermittent disease  
• Symptoms fewer than 2 times a week,
• Pulmonary function is normal between exacerbations.
• Exacerbations are brief, lasting from a few hours to a few days
• Nighttime symptoms occur less than twice a month. 
• The variation in peak expiratory flow (PEF) is less than 20%.
Mild persistent asthma
• Symptoms more than 2 times a week but less than once a day.
• Exacerbations may affect activity.
• Nighttime symptoms occur more than twice a month..
• Pulmonary function test results demonstrate that the forced expiratory volume 
in 1 second (FEV1) or PEF is less than 80% of the predicted value, and the 
variation in PEF is 20-30%.
Moderate persistent asthma 
• Daily symptoms, use inhaled short-acting beta2-agonists every day.
• Acute exacerbations in patients- more than 2 times a week and last for day
• The exacerbations affect activity. 
• Nocturnal symptoms occur more than once a week. 
• FEV1 and PEF values are 60-80% of the predicted values
• PEF varies by more than 30%.
Severe persistent asthma      
• Continuous or frequent symptoms.
• Limited physical activity.
• Frequent nocturnal symptoms.
• FEV1 and PEF are less than 60% of the predicted values.
• PEF varies by more than 30%.
Since signs and symptoms of asthma and pneumonia have considerable overlap, 
in current WHO ARI CASE MANAGEMENT guidelines, in a child presenting with 
cough and rapid breathing, there is a predilection for over -treatment of pneumonia and 
under treatment of asthma.
                      
LITERATURE REVIEW
          Sachdev H.P.S et al conducted a case control comparison among children of acute 
asthma (n=100) and ARI (n=100), in 1995 in an urban referral centre- New Delhi. Only 
34%  of  asthmatics  had  an  audible  wheeze.  Significant  independent  predictors  on 
multiple logistic regression analysis were number of earlier similar attacks and fever (or 
temperature). The best predictors for asthma were two or more earlier similar episodes 
(sensitivity 84%, specificity 84%) followed by temperature < 37.6°C (sensitivity 73% 
and specificity 84%). Absence of fever, audible wheeze and a family history of asthma 
had excellent specificity (98-100%) but low sensitivity (20-34%). It is concluded that 
simple clinical predictors can differentiate acute asthma and ARI. The recommended 
case management can, therefore, be refined by either: (i) Prescribing bronchodilators 
and  no  antibiotics  with  two  or  more  earlier  similar  episodes  of  cough  and  rapid 
breathing;  or  (ii)  To  further  minimize  under  treatment  for  pneumonia,  prescribing 
bronchodilators as above, but denying antibiotics in such cases only if there is audible 
wheeze or family history of asthma or no fever22.
Sachdev  H.P.S.,  in  the  year  2001,  conducted  a  study  in  New  Delhi,  in  200 
children presenting with acute onset of cough and respiratory distress. Those children in 
whom  there  was  a  previous  similar  episode  were  challenged  with  bronchodilator 
nebulisation. Their response to bronchodilator was then evaluated. Acute asthma was the 
predominant condition (46% or 54%), pneumonia alone was rare (10%), co-existence of 
pneumonia with wheeze (bronchospasm) was more frequent (22% or 15%) and often 
diagnoses not related to the respiratory system were documented (18% or 17%). All the 
subjects in whom a preceding history of cough was not  elicited had non-respiratory 
illnesses. An audible wheeze was appreciated in only 44 of the 150 cases (29.3%) with 
an auscultable wheeze. Conclusion: It is feasible to amalgamate simple clinical features 
(history of: (i) previous similar episode of cough and difficult breathing, and (ii) fever) 
in the WHO case management algorithm to significantly refine the antibiotic (95% CI 
range 7% to 33%) and bronchodilator (35%; 95% CI 27% to 43%) prescription23. .
A multicentric study conducted in Pakistan by Hazir T et al on 1622 children aged 
between 6 months to 5 years, who presented with cough and respiratory distress with 
either  auscultatory  or  audible  wheeze  were  given  3  cycles  of  bronchodilator.  The 
response  of  tachypnoea  to  bronchodilator  was  then  evaluated.  Result:  Among  1004 
children  who  were  classified  as  having  non  severe  pneumonia  according  to  WHO 
classification,  621(61.8%)  responded  to  bronchodilator.  383  children  who  were 
classified as   severe pneumonia based on WHO classification, 145(38.14%) responded 
to bronchodilator24.
           A study was conducted by AV Castro et al in Brazil, in the year 2005, on 182 
children, presenting with cough and tachypnoea. Each child had a chest X-ray that was 
read by two blinded, independent radiologists. Discordance between the two radiologists 
led to excluding 17 patients. The remaining 165 children were examined for fever and/or 
chest indrawing, and if they had a history of previous respiratory distress, challenged 
with  a  bronchodilator  (BD).  The  association  of  persistent  tachypnoea  after  BD and 
presence of pulmonary infiltrates was recorded. Results: The median age was 22 months 
(mean 25.1±14.5mo) and 75.8% were aged >1 year. There were 58.8% males. Previous 
respiratory distress occurred in 65.0% and 79.2% of children aged <1 year and    >1 
year,  respectively.  Pneumonia  was  radiologically  diagnosed in  26/165 (15.8%).  2/40 
(5%)  of  children  without  a  history  of  previous  respiratory  distress  had  pneumonia 
diagnosed. Of 125 children with history of previous respiratory distress, pneumonia was 
identified  in  24  (19.2%).  Persistence  of  tachypnoea  after  BD  was  associated  with 
pulmonary infiltrate in 14/24 (58.3%), whereas, tachypnoea persisted in 32/101 (31.7%) 
children  without  pulmonary  infiltrates  (P  =  0.02).  The  negative  predictive  value  of 
resolution of tachypnoea was 87.3% (95% CI 77.5-93.4). BD non-response was most 
useful in children without fever and/or with chest indrawing to indicate pneumonia as 
the cause of the tachypnoea. This study indicates that by adding the simple procedures 
of a history of previous respiratory distress, recording of fever and chest indrawing, and 
observing  the  response  to  bronchodilators,  pneumonia  can  be  reliably  identified  in 
children  presenting  with  tachypnoea  and cough.  It  is  probable  that  this  approach to 
management of children with cough and tachypnoea could reduce unnecessary use of 
antibiotics. Negative predictive value for resolution of tachypnoea-87.3%25.
In a multicentric study in Thailand in the year 2004, 521 children with wheeze 
were  screened,  256  (49.1%)  had WHO defined  non-severe  and  265  (50.9%)  severe 
pneumonia.  Wheeze  was  audible  in  only  48  (9.2%)  of  children  Of  256  non-severe 
pneumonia children, 217 (84.8%) responded to up to three cycles of bronchodilator. Of 
265 severe pneumonia children, 189 (71.3%) responded. Among responders, 14 (6.4%) 
children  in  non-severe  and  24  (12.7%)  in  the  severe  pneumonia  group  showed 
subsequent deterioration on follow-ups. A body temperature more than 100°F (37.7°C) 
and  severe  pneumonia  were  identified  as  independent  predictors  of  subsequent 
deterioration26.
           A study was conducted by Okoromah CN et al in Lagos to find out the rates of 
diagnosis and treatment of asthma among private practitioners. Relevant information on 
45  asthmatic  children  was  collected  using  pre-tested  questionnaires.  There  were  30 
(66.7%) males and 15 (33.3%) females (M:F, 2:1). Mean age, average ages for onset of 
symptoms and diagnosis of asthma were 9.4 years, 1.8 years and 6.6 years respectively. 
An average of 4 previous medical consultations were undertaken for asthma symptoms, 
but  only  11  (24.4%)  cases  were  labeled  as  asthma.  Alternative  diagnostic  labels 
including allergy, bronchitis (wheezy), pneumonia (chest infection), and tuberculosis, 
were used in 29 (64.4%). Five (11.1%) cases were unlabelled. Alternative labeling for 
asthma was associated with frequent usage of non-bronchodilator medications including 
antihistamines,  antibiotics,  antituberculous  drugs,  cough  mixtures,  and  herbal 
concoctions.  Only  15  (33.3%)  cases  received  bronchodilators,  rarely  prescribed 
regularly in the absence of asthma label. This study reveals low diagnosis and treatment 
rates for asthma, emphasising the need to audit the management of childhood asthma 
among medical practitioners, with the view of providing information27.
STUDY JUSTIFICATION
According  to  WHO  ARI  CASE  MANAGEMENT2 guidelines,  any  child 
presenting with cough and rapid breathing, is indicative of pneumonia and the empirical 
treatment with antibiotics is suggested presuming bacterial etiology.
It  is  important  to consider  that  asthma does occur  in  children presenting with 
cough and fast breathing which can be treated with only bronchodilators15.
The various studies conducted all over the world22,23,24,25,26 also emphasise that the 
current WHO guidelines for ARI management leads to over treatment of pneumonia and 
under treatment of asthma. The present study was designed to find out the “Predictors” 
that can reliably distinguish acute pneumonia from asthma in children 6 months to 5 
years.  This will  also reduce the unnecessary antibiotic use and enable timely use of 
bronchodilators.
OBJECTIVES OF THE STUDY
 To study the value of
• Fever, chest indrawing and the response of tachypnoea to bronchodilator individually 
and in combination in predicting pneumonia among children aged 6 months to 5 
years attending urban referral center.
• H/O  previous  similar  episodes,  H/O  prior  nebulisations,  family  H/O  asthma  in 
predicting asthma
SUBJECTS AND METHODS
Study design: Descriptive study
Study  place: Out patient department
Study period: 2005-2007
Study population: 
Inclusion criteria: 
Children (6 months-5years) presenting with 
• H/O acute cough,
• Respiratory distress,
• Fever
Exclusion criteria:
 Severe malnutrition,
 foreign body inhalation,
 chronic illness,
 H/O prior treatment with antibiotics ,
 grunt,
 stridor,
 cyanosis,
 unstable vitals,
 known asthmatic
Sample size:  245
Prevalence of ARI is 20%
Power was 80%,and 
Alpha was 5%,
So the sample size calculated is,
n=z2 P(1-P)/d2
  = 245
n= sample size
z=1.96,
Precision (d)=0.05,
Prevalence (P)=0.20
Manoeuvre:  Figure A : Flow paths of cases in the study:
*Bronchodilator:3 doses of beta2 agonist 0.1mg/kg/dose,each 20 minutes.
Cough and fast breathing ( if fever present - 
treatment of fever before counting respiratory rate)
Respiratory rate
Tachypnoea No tachypnoea
H/O previous similar episode 
and/or audible wheeze
No Yes
Admission Bronchodilator*
Tachypnoea
    Yes    No
Admission
Bronchodilator*
and follow up
Diagnostic Definitions
Clinical diagnosis of pneumonia was made before reading the chest X-ray, if the 
respiratory frequency had not reduced under the cutoff limit for respective age stratum 
after three nebulisations. 
Only Radiological  diagnosis  of  pneumonia confirmed by two radiologists  was 
considered as  Gold standard.  Agreement  on interpretation of  infiltrates  between two 
pediatric radiologists was necessary for evaluation in the study.
The radiologists were not given clinical information and considered only three 
radiological  patterns:  (i)  normal,  (ii)  presence  of  pulmonary  infiltrates  (reduced 
pulmonary view), or (iii) pulmonary hyperinflation without pulmonary infiltrate, based 
on WHO standards and definitions applied for epidemiological studies28.
Bronchospasm  was  diagnosed  if  there  was  wheeze,  absence  of  pulmonary 
infiltration on chest  X-ray and rapid improvement (reduction of respiratory rate below 
cutoff limit for each age) after bronchodilator therapy.
Co-existence of bronchospasm and pneumonia was defined if the respiratory rate 
decreased and there was concomitant pulmonary infiltrate on X-ray. 
STATISTICAL ANALYSIS
Proportions  of  the  children  who  had  persistent  tachypnoea  following 
bronchodilator therapy and those in whom tachypnoea resolved were arrived at.  The 
sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) 
and accuracy of the persistent  tachypnoea following bronchodilator therapy, fever, chest 
indrawing in predicting pneumonia (infiltrates in the chest X ray) individually and in 
combination were arrived at among the entire study population.  The same analysis was 
applied after excluding those children who had more than two previous similar episodes, 
family H/O asthma or allergy, previous nebulisations either alone or in combination, 
presence of these would point  more towards asthma as the cause of  cough and fast 
breathing.  P < 0.05 was considered to be statistically significant.
RESULTS
Total No. of children in the study   :  245
* 4 
excluded due to discordance in chest x ray
245 children
  36 children
 (first episode)
  Admission
209 children
(H/O previous 
similar episode)
     *4 children
       excluded
  
     205 children
    Bronchodilator
135 – No tachypnoea
  70 – Persistent tachypnoea
Particulars of children who were excluded from the study
Sex
Response to 
bronchodilator
CXR 
Radiologist 1
CXR 
Radiologist 2
Female Settled Normal Bronchopneumonia
Female Not settled BHI Retrocardiac pneumonitis
Male Not  Settled Normal
Bronchopneumonia with 
obstructive emphysema
Female Not settled Normal Mild cardiomegaly
Table 1:  First episode of respiratory distress (n=36)
Pneumonia
Male Female
n % n %
Total
Yes 12 50.0 10 27.7 22
No 10 27.7 4 11.1 14
Table 2:   Symptoms and History analysis of 36 children
Symptoms + History No. of children (n ) Percentage (%)
Fever 25 69.44
Cough + cold 36 100
Fast breathing 36 100
Chest indrawing 24 66.66
Decreased feed intake 27 75
Lethargy 27 75
Running nose 26 72.22
Vomiting 19 52.77
Audible wheeze 13 36.12
Cyanosis 0 0
Family H/O allergy 
/asthma
0 0
Previous H/O nebulisations 1 2.77
Previous similar episode 0 0

Table 3:  Signs elicited in the 36 children
Signs No. of children (n) Percentage (%)
Temperature > 
37.4°C
29 80.55
Undernutrition 31 86.11
Wheeze 1 2.77
Crepitations 35 97.22
Table 4:  Symptoms and History analysis of 205 children
Symptoms + History No. of children (n) Percentage (%)
Fever 97 47.31
Cough + cold 205 100
Fast breathing 205 100
Chest indrawing 82 40
Decreased feed intake 123 60
Lethargy 44 21.46
Running nose 52 25.36
Vomiting 37 18.04
Audible wheeze 30 14.63
Cyanosis 0 0
Family H/O allergy 
/asthma 47 22.92
Previous H/O 
nebulisations 80 30.92
Previous H/O 
respiratory distress 205 100
One episode 133 64.87
More than two 
episodes 72 35.12

Table 5:  Signs elicited in the 205  children
Signs No. of children (n) Percentage (%)
Temperature > 37.4°C 97 47.31
Undernutrition 123 60
Wheeze 164 80
Crepitations 189 92.19
205 children had a previous similar episode of cough and rapid breathing received 
bronchodilator challenge. The response of  tachypnoea was then evaluated.
Table  6  : Association  between  persistence  of  tachypnoea  after 
bronchodilator challenge and Pneumonia
Tachypnoea
X ray infiltrate
Yes No
Total
Yes 56 14 70
No 20 115 135
Total 76 129 205
Sensitivity : 73.68% ,  Specificity : 89.14%,   PPV : 80%,  NPV : 85.18%
Among 76 children who had infiltrates radiologically, 56 children had persistent 
tachypnoea  after  trial  bronchodilator.  In  20  children  tachypnoea  disappeared 
(Sensitivity:  73.68).  Out  of  129 children  who had no infiltrates  on chest  x  ray  115 
children  showed resolution of  tachypnoea  following bronchodilator.  But  14  children 
continued  to  have  persistent  tachypnoea  despite  normal  chest  x  ray  (Specificity: 
89.14%). Out of 70 children with persistent tachypnoea, 56 children had infiltrates on 
chest x ray. (PPV = 80%). Out of 135 children whose tachypnoea resolved following 
bronchodilator, 115 children had normal x ray. (NPV = 85.18%).   p< 0.05. Overall 
accuracy  of  persistant  tachypnoea  after  bronchodilator  in  predicting  pneumonia  is 
83.41%.
 
Table 7: Association between Fever and Pneumonia
Fever
X ray infiltrate
Yes No
Total
Yes 60 37 97
No 16 92 108
Total 76 129 205
Sensitivity  :  78.94%  ,   Specificity  :  71.31%  ,   PPV  :  61.85%,    
NPV : 85.18%
Evaluating fever as a sign in predicting pneumonia against the gold standard of 
radiological infiltrate, 60 children who had fever had infiltrate in chest x ray. 16 children 
who did not have fever had infiltrate (Sensitivity: 78.94%). Out of 129 children who had 
normal x ray 92 did not have fever (Specificity: 71.31%). p<0.05. Overall accuracy of 
fever in predicting pneumonia is 74.14%. 
             
Table 8 : Association between Chest indrawing and Pneumonia
Chest indrawing
X ray infiltrate
Yes No
Total
Yes 70 12 82
No 6 117 123
Total 76 129 205
Sensitivity : 92.10%,    Specificity : 90.69%,   PPV : 85.36%,   NPV:95.12%
70/76  who had chest indrawing showed x ray infiltrate (Sensitivity: 92.10%). Out 
of  129  children  with  normal  chest  x  ray,  117  children  had  no  chest  indrawing 
(Specificity : 90.69). 82 children with chest indrawing, 70 children had x ray infiltrates 
( PPV : 85.36%). Of the 123 children who did not have chest indrawing, 117 children 
had  normal  chest  x  ray  (  NPV :  95.12%).  p<  0.05.  The  overall  accuracy  of  chest 
indrawing in predicting pneumonia is 91.21%.
Table  9:  Association  between  fever  and  persistence  of  tachypnoea    
                and  pneumonia
Fever + 
persistent tachypnoea
X ray infiltrate
Yes No
Total
Yes 53 17 70
No 23 112 135
Total 76 129 205
Sensitivity : 69.73% ,  Specificity : 86.82%,   PPV : 75.71%,  NPV:82.96%
53/70  children  who  had  fever  at  presentation  and  showed  no  response  of 
tachypnoea  to  bronchodilator  had  infiltrate  on  chest  x  ray  (PPV :  75.71%).  23/135 
children who had neither fever nor persistant tachypnoea following bronchodilator had 
infiltrate  on chest  x  ray.  On the other  hand 17/70 children who had both fever  and 
persistant tachypnoea after bronchodilator showed no infiltrate. 112/129 children were 
afebrile  and  tachypnoea  disappeared  after  bronchodilator  had  normal  chest  x  ray. 
(Specificity:  86.82%).   p< 0.05.  Accuracy  of  combined  presence  of  both  fever  and 
persistent tachypnoea in predicting pneumonia is 80.48%.  
Table  10:  Association  between  chest  indrawing  and  persistence  of  
                   tachypnoea and pneumonia
Chest indrawing + 
persistent tachypnoea
X ray infiltrate
Yes No
Total
Yes 61 9 70
No 15 120 135
Total 76 129 205
s
Sensitivity : 80.26%,   Specificity : 93.02%,   PPV : 87.14% ,  NPV:88.88%.
61/76 children who had both chest indrawing and persistent tachypnoea following 
bronchodilator had infiltrate on chest x ray (Sensitivity:80.26%) . 120/129 children who 
did not  have chest  indrawing and who showed good response to bronchodilator  had 
normal  chest  skiagram(Specificity:  93.02%).  p  <  0.05.  Accuracy  of  the  combined 
presence  of  chest  indrawing  and  persistent  tachypnoea  in  predicting  pneumonia  is 
88.29% 
Table 11:  Fever, chest indrawing and  persistence of  tachypnoea in   
          combination, in predicting pneumonia
Fever + Chest indrawing + 
Persistent tachypnoea
X ray infiltrate
Yes No
Total
Yes 65 5 70
No 11 124 135
Total 76 129 205
Sensitivity : 85.52% , Specificity : 96.12% , PPV : 92.85% , NPV:91.85%.
65/76  children  who  had  combined  presence  of  fever,  chest  indrawing  and 
persistent tachypnoea showed x ray infiltrates ( Sensitivity : 85.52%).  124/129 children 
who did not have all the three characteristics had normal x ray  ( Specificity : 96.12% ). 
65/70 children who had infiltrates in x ray had fever, chest indrawing with persistence of 
tachypnoea in combination (PPV : 92.85% ). Out of 135 children who had neither of 
these characteristics,124 children were with normal chest skiagram ( NPV : 91.85%). p 
< 0.05.  The  combined presence  of  fever,  chest  indrawing and persistent  tachypnoea 
following bronchodilator in predicting pneumonia has an excellent accuracy of 92.19% .
There  were  72  children  who  had  either  more  than  two  previous  similar 
episodes and/or family history of asthma and/or previous history of nebulisations  
• More than two similar episodes –  42. 
• Family h/o asthma  –13
• H/o previous nebulisations – 17 
Presence of these factors either single or in combination may more likely suggest 
that ASTHMA may be the cause of cough and respiratory distress.
So we excluded these children and applied the same analysis in the rest  (n = 133).
Table 12: Association between persistence of tachypnoea after 
           bronchodilator challenge and pneumonia
Tachypnoea
X ray infiltrate
Yes No
Total
Yes 54 6 60
No 16 57 73
Total 70 63 133
Sensitivity  :  77.14%,    Specificity  :  90.46%,    PPV  :  90.00%,  
NPV : 78.08%
After excluding children who were more likely to be asthmatics, 54/70 children 
showed infiltrates on chest x ray had persistent tachypnoea. 16/70 children in whom 
tachypnoea  resolved  had  infiltrates.  (Sensitivity  :  77.14%).  57/63  children  in  whom 
tachypnoea  disappeared  following  bronchodilator  had  normal  x  ray.  (Specificity  : 
90.46% an increase from 89.14%). P < 0.05.
Table 13: Association between fever and pneumonia
Fever
X ray infiltrate
Yes No
Total
Yes 62 11 73
No 8 52 60
Total 70 63 133
Sensitivity  :  88.57%,   Specificity  :  82.53%,    PPV  :  84.93%,    
NPV : 86.66%
Sensitivity  of  fever  in  predicting  pneumonia  is  88.57%.  On  excluding  the 
population of children in whom the cause of tachypnoea was likely to be asthma the 
specificity  of fever in predicting pneumonia increased from 71.31% to 82.53%. p < 
0.05.  
Table 14 : Association between chest indrawing and pneumonia
Chest indrawing
X ray infiltrate
Yes No
Total
Yes 65 5 70
No 5 58 63
Total 70 63 133
Sensitivity : 92.85%, Specificity : 92.06%,   PPV : 92.85%,   
NPV : 92.06%.
65/70 children, who had infiltrate presented with chest indrawing. 58/63 who did 
not have chest indrawing had normal chest x ray. Specificity has increased from 90.69% 
to  92.06%  in  these  children.  
P < 0.05.
Table 15: Association between fever and  persistence of 
          tachypnoea and   pneumonia
Fever+ 
persistent tachypnoea
X ray infiltrate
Yes No
Total
Yes 53 5 60
No 17 58 73
Total 70 63 133
 
Sensitivity  :  75.71%,  Specificity  :  92.06%,  PPV  :  88.33%  ,  
NPV : 79.45%.
The combined presence of both fever and persistent tachypnoea in these children 
whose etiology for tachypnoea were more likely to be asthma has got a specificity of 
92.06. There is an increase from 86.82% to 92.06% in these children when compared to 
the entire study population. P < 0.05
Table 16 :  Association between chest indrawing and  persistence of  
          tachypnoea  and  pneumonia    
Chest indrawing + 
persistent tachypnoea
X ray infiltrate
Yes No
Total
Yes 57 3 60
No 13 60 73
Total 70 63 133
Sensitivity : 81.42%,   Specificity : 95.23%,   PPV: 95%,   NPV: 82.19%
The combined presence of both chest  indrawing and Tachypnoea also showed 
increase in specificity from 93.02% to 95.23% in diagnosing pneumonia. P < 0.05.
Table 17: Association  between  fever,  chest  indrawing  and   
                     persistence of   tachypnoea and pneumonia
Fever + Chest indrawing + 
Persistent tachypnoea
X ray infiltrate
Yes No
Total
Yes 58 2 60
No 12 61 73
Total 70 63 133
Sensitivity  :  82.85%,   Specificity  :  96.82%,  PPV  :  96.66%,   
NPV : 83.56%.
The simultaneous presence of fever, chest indrawing and persistent tachypnoea 
after  bronchodilator  in  predicting  pneumonia  is  highly  specific  for  pneumonia. 
Specificity: 96.82% There is no significant increase in specificity in this study group 
when compared to the entire study population.
TABLE 18: 
Association  of 
pneumonia with the 
following
Sensitivity (%) Specificity (%)
n1= 205 n2= 133 n1= 205 n2= 133
Persistent tachypnoea 73.68 77.14 89.14 90.46
Fever 78.94 88.57 71.31 82.53
Chest indrawing 92.10 92.85 90.69 92.06
Fever +  Persistent 
tachypnoea
69.73 75.71 86.82 92.06
Chest indrawing + 
Persistent tachypnoea
80.26 81.42 93.02 95.23
Fever +  
Chest indrawing + Persistent 
tachypnoea
85.52 82.85 96.12 96.82
   n1: Entire study population            n2: excluding likely asthmatics
FOLLOW UP
On follow up of 115 children who were sent home with bronchodilator after two 
days,  only 47 children came for  follow up (40.86%).  Of these 47 children 39 were 
normal, 5 children had another acute attack.  They were treated with bronchodilator. 3 
children who initially had fever and chest indrawing got deteriorated and hence were 
admitted.
DISCUSSION
At  the  time  of  conception  of  case  management  of  WHO guidelines  for  case 
management of childhood pneumonia in early eighties, pneumonia was assumed to be 
the predominant condition presenting with cough, cold and fast breathing1,2. Upto this 
time  enough  data  has  been  accumulated  to  highlight  the  increasing  prevalence  and 
severity of asthma globally11,13,14. There is a considerable overlap in clinical presentation 
of pneumonia and asthma. It is also important to emphasise that asthma related fatalities 
do occur 20,21 and can be effectively prevented by accurate diagnosis and early institution 
of treatment with bronchodilators.
WHO-IMNCI case management of ARI was developed in order to assist the field 
workers to reliably identify children with ARI and to institute treatment. It also enables 
them identify those children who need to be immediately referred to hospital2,8. It has 
also been advocated to treat the children presenting with recurrent wheeze (audible) with 
trial of bronchodilators15,26.
 Further,  the  need  for  bronchodilator  therapy  is  guided  by  the  presence  of  a 
wheeze  which  for  paramedical  personnel  pertains  to  only  an  estimated  one-third 
episodes in which the wheeze may be audible without the aid of a stethoscope26.
 Thus,  according  to  the  current  guidelines,  in  a  child  with  cough  and  rapid 
breathing, there is a predilection for over-treatment for pneumonia with antibiotics and 
for under-treatment for asthma with broncho-dilators22,23,25. 
In this study, there were 205 children between 6 months to 59 months age group 
presented  with  acute  cough and respiratory  distress  with  previous  history  of  similar 
episode.  These  children  received  trial  nebulisations  with  careful  monitoring.  The 
response of tachypnoea to nebulisations was then assessed. 135/205 children showed 
good response to nebulisations and their tachypnoea resolved. 115/135 children had a 
normal chest skiagram (NPV: 89.14%). Fever, defined as temperature of >37.4°C, has 
specificity  of  71.31%  in  predicting  pneumonia.  Chest  indrawing  had  an  excellent 
specificity of 90.69%. However the combined presence of fever, chest indrawing and 
persistent tachypnoea in predicting the presence of infiltrates on chest x ray has a very 
high sensitivity of 85.52% and specificity of 96.12%.
There were 72 children, who either had more than two similar episodes and/or 
family H/O asthma and/or previous H/O nebulisations; in these children acute cough and 
respiratory distress may have been due to asthma.  Excluding these 72 children the same 
analysis was done in the rest 133 children. As expected the specificities of fever, chest 
indrawing and persistent tachypnoea either alone or in combination showed an increase 
from the entire study population indicating the clinical picture could have been due to 
asthma.
In short, pneumonia (presence of infiltrates on chest x ray) was diagnosed only  in 
76/205 children ( 37.07%) which is in accordance with the great importance of asthma 
as a cause of respiratory distress.
 There are similar such studies which also found a low prevalence of pneumonia 
in children presenting with cough and rapid breathing. Study conducted by A.V Castro 
et al in Brazil25 showed that pneumonia was radiologically diagnosed in only 15.8% of 
the children who presented with cough and rapid breathing. Another study conducted by 
H.P.S. Sachdev et al 22,23 in New Delhi also showed only 10% of x ray showing infiltrate 
in similar children.
This  study  demonstrated  association  between  persistent  tachypnoea  after 
bronchodilator  in  children  with  previous  H/O  respiratory  distress  and  presence  of 
pulmonary infiltrate (p = 0.0001). By employing this algorithm, 85.18% of children did 
not receive unnecessary antibiotics.
 This is in accordance with the study conducted by A.V. Castro et al where the 
NPV  of  resolution  of  tachypnoea  after  trial  with  bronchodilator  was  87.3%25.  The 
response to bronchodilator in children with previous history of respiratory distress could 
reduce  the  use  of  antibiotics  in  regions  where  there  is  an  increasing  prevalence  of 
asthma. This would also prevent the problem of development of antimicrobial resistance 
by unnecessary use of antibiotics6,29,30.
Presence of fever at the onset, has a good specificity in diagnosis of pneumonia. 
This is not in accordance with the study by A.V.Castro which showed no significant 
association between fever and pneumonia25.  But our Indian study conducted in New 
Delhi in 1995 showed absence of fever is associated with asthma rather pneumonia22.
 The presence of chest indrawing is significantly associated with pneumonia ,with 
a very high specificity of 90.69%. This is not in accordance with the result of the study 
conducted in Brazil by A.V. Castro25 where the presence of chest indrawing has a poor 
correlation  with  pneumonia.  The  presence  of  fever,  chest  indrawing  and  persistent 
tachypnoea has a significant association with the presence of infiltrate in chest x ray 
with the highest specificity of 96.12%.
On  excluding  72  children  who  either  had  previous  H/O  nebulisations  and/or 
family H/O asthma, and/or more than two episodes in whom asthma may be a cause of 
cough  and  respiratory  distress  the  specificity  of  fever,  chest  indrawing,  persistent 
tachypnoea  either  alone  or  in  combination  in  diagnosis  of  pneumonia  (presence  of 
infiltrate) increased. 
This is in accordance with the result of the study conducted by H.P.S Sachdev 
1994 which showed that the best predictor for asthma was two or more earlier similar 
episodes  (sensitivity84%,  specificity84%)    followed  by  temperature  <37.6°C 
(sensitivity 73% and specificity 84%). Absence of fever, audible wheeze and a family 
history of asthma had excellent specificities (98-100%) but low sensitivities (20-34%). It 
is  concluded that  these simple clinical  predictors  can differentiate  acute  asthma and 
ARI22,23. 
                                                                      SUMMARY
To summarize the results of the study, 
• The  combination  of  fever,  chest  indrawing and  persistent  tachypnoea  after 
bronchodilator  has  an  excellent  specificity  of  96.12%  in  predicting  the 
presence of pulmonary infiltrate
• Correction  of  tachypnoea  after  bronchodilator  therapy has  a  good negative 
predictive value of 85.18% in the diagnosis of pneumonia.
• The  presence  of  more  than  two  episodes  of  similar  respiratory  distress, 
previous  H/O  of  nebulisations  and  family  H/O asthma,  either  alone  or  in 
combination  may  point  more  towards  asthma  as  a  cause  of  cough  and 
respiratory distress.
CONCLUSION
• In a child presenting with cough and fast breathing with a previous similar 
episode,  trial  nebulisations  can  be  given  before  investigating  further  for 
pneumonia.
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ANNEXURE
DATA ENTRY FORM
     Serial No:
     Name:
     Age:
     Weight:
      Sex:
      Father’s name:
      Address:
      Complaints:
      
       H/O previous similar episodes:
       H/O antibiotic use:
       Foreign body aspiration:
       Lethargy:
       Decreased activity:
       Decreased intake of feeds:
       Convulsions:
       Audible wheeze:
       H/O bluish discoloration 
       of tongue and nail bed:
       H/O altered sensorium:
       H/O of vomiting and/ loose stools:
       H/O decreased urine output:
       Known case of asthma:
    
       Family H/O asthma and/ allergy:
       H/O other chronic illness:
                                            Examination
Nutritional status:
Hydration status:
Temperature:
Respiratory system: 
Respiratory rate:
Chest indrawing:
Nasal flaring:
Grunt:
Cyanosis:
Stridor
Audible wheeze:
Air entry:
Added sounds:
Cardiovascular system: 
Apex:
Heart sounds:
Murmur:
Abdomen: 
Organomegaly:
Central nervous system: 
Higher function:
Pupils:
Focal deficit: 
                                                                                                        
Bronchodilator Cough Respiratory rate Chest indrawing
        
Chest X ray:
Advice:
Follow up:
